Edgewise Therapeutics logo

Edgewise Therapeutics Share Price Today

(NASDAQ: EWTX)

Edgewise Therapeutics share price is $26.71 & ₹2,322.94 as on 6 Mar 2025, 2.30 'hrs' IST

$26.71

2.21

(9.02%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Edgewise Therapeutics share price in Dollar and Rupees. Guide to invest in Edgewise Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Edgewise Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Edgewise Therapeutics share price movements

  • Today's Low: $24.35
    Today's High: $26.77

    Day's Volatility :9.06%

  • 52 Weeks Low: $14.90
    52 Weeks High: $38.12

    52 Weeks Volatility :60.91%

Edgewise Therapeutics (EWTX) Returns

PeriodEdgewise Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-15.39%
3.7%
0.0%
6 Months
52.89%
-2.8%
0.0%
1 Year
57.12%
2.5%
0.0%
3 Years
148.47%
12.9%
-11.6%

Edgewise Therapeutics (EWTX) Key Statistics

in dollars & INR

Previous Close
$24.5
Open
$24.6
Today's High
$26.77
Today's Low
$24.345
Market Capitalization
$2.3B
Today's Volume
$767.3K
52 Week High
$38.12
52 Week Low
$14.9
Revenue TTM
$0.0
EBITDA
$-156.8M
Earnings Per Share (EPS)
$-1.39
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-34.4%

How to invest in Edgewise Therapeutics Stock (EWTX) from India?

It is very easy for Indian residents to invest directly in Edgewise Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Edgewise Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Edgewise Therapeutics or EWTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Edgewise Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Edgewise Therapeutics shares which would translate to 0.033 fractional shares of Edgewise Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Edgewise Therapeutics, in just a few clicks!

Returns in Edgewise Therapeutics (EWTX) for Indian investors in Rupees

The Edgewise Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Edgewise Therapeutics investment value today

Current value as on today

₹1,62,066

Returns

₹62,066

(+62.07%)

Returns from Edgewise Therapeutics Stock

₹57,118 (+57.12%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Edgewise Therapeutics (EWTX)

17%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Edgewise Therapeutics Stock from India on INDmoney has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Edgewise Therapeutics

  • Orbimed Advisors, LLC

    15.86%

  • RA Capital Management, LLC

    9.41%

  • BlackRock Inc

    6.84%

  • Baker Bros Advisors LP

    6.50%

  • Novo A/S

    5.28%

  • HHG PLC

    5.26%

Analyst Recommendation on Edgewise Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Edgewise Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Edgewise Therapeutics Stock (EWTX)

What analysts predicted

Upside of 76.43%

Target:

$47.13

Current:

$26.71

Insights on Edgewise Therapeutics Stock (Ticker Symbol: EWTX)

  • Price Movement

    In the last 6 months, EWTX stock has moved up by 52.5%
  • EWTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 9.4%

Edgewise Therapeutics Technicals Summary

Sell

Neutral

Buy

Edgewise Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Edgewise Therapeutics (EWTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Edgewise Therapeutics Inc logo
-9.46%
52.89%
57.12%
148.47%
-6.54%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Edgewise Therapeutics Inc logo
3.7
NA
NA
-1.92
-0.34
-0.24
NA
4.84
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Edgewise Therapeutics Inc logo
Buy
$2.3B
-6.54%
3.7
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Edgewise Therapeutics

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.
Organization
Edgewise Therapeutics
Employees
108
CEO
Dr. Kevin Koch Ph.D.
Industry
Healthcare

Management People of Edgewise Therapeutics

NameTitle
Dr. Peter A. Thompson FACP, M.D.
Co-Founder & Independent Chairman
Dr. Kevin Koch Ph.D.
President, CEO & Director
Dr. Badreddin Edris Ph.D.
Co-Founder & Independent Director
Dr. Behrad Derakhshan Ph.D.
Chief Operating Officer
Dr. Joanne M. Donovan M.D., Ph.D.
Chief Medical Officer
Dr. Alan J. Russell Ph.D.
Co-Founder, Chief Scientific Officer & Director
Mr. R. Michael Carruthers
Chief Financial Officer
Mr. John R. Moore J.D.
General Counsel
Dr. Robert Blaustein M.D., Ph.D.
Chief Development Officer

Important FAQs about investing in EWTX Stock from India :

What is Edgewise Therapeutics share price today?

Edgewise Therapeutics share price today stands at $26.71, Open: $24.60 ; Previous Close: $24.50 ; High: $26.77 ; Low: $24.35 ; 52 Week High: $38.12 ; 52 Week Low: $14.90.

The stock opens at $24.60, after a previous close of $24.50. The stock reached a daily high of $26.77 and a low of $24.35, with a 52-week high of $38.12 and a 52-week low of $14.90.

Can Indians buy Edgewise Therapeutics shares?

Yes, Indians can invest in the Edgewise Therapeutics (EWTX) from India.

With INDmoney, you can buy Edgewise Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Edgewise Therapeutics at zero transaction cost.

How can I buy Edgewise Therapeutics shares from India?

It is very easy to buy Edgewise Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Edgewise Therapeutics (EWTX) be purchased?

Yes, you can buy fractional shares of Edgewise Therapeutics with INDmoney app.

What are the documents required to start investing in Edgewise Therapeutics stocks?

To start investing in Edgewise Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Edgewise Therapeutics Stock (EWTX)?

Today’s highest price of Edgewise Therapeutics (EWTX) is $26.77.

Today’s lowest price of Edgewise Therapeutics (EWTX) is $24.35.

What is today's market capitalisation of Edgewise Therapeutics?

Today's market capitalisation of Edgewise Therapeutics EWTX is 2.3B

What is the 52 Week High and Low Range of Edgewise Therapeutics Stock (EWTX)?

  • 52 Week High

    $38.12

  • 52 Week Low

    $14.90

What are the historical returns of Edgewise Therapeutics (EWTX)?

  • 1 Month Returns

    -9.46%

  • 3 Months Returns

    52.89%

  • 1 Year Returns

    57.12%

  • 5 Years Returns

    -6.54%

Who is the Chief Executive Officer (CEO) of Edgewise Therapeutics ?

Dr. Kevin Koch Ph.D. is the current Chief Executive Officer (CEO) of Edgewise Therapeutics.

Discover More